Search

everythinglearnresearchcommunity

for

Search:↓

Combining low-dose dutasteride with finasteride improved a man's hair loss.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Topical Minoxidil effectively and safely regrows hair in cancer patients.

Biological therapy boosts the immune system to effectively fight melanoma.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.

Zinc sulphate may help reduce skin damage from radiation therapy.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Dutasteride may help shrink prostate cancer tumors.

Eruca sativa oil, Aloe vera oil, and sodium carbonate may help improve cholesterol and tumor markers in breast cancer treatment.

Targeted cancer therapies often cause serious skin problems that need careful management.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Oral minoxidil may effectively treat hair loss from chemotherapy.

The combination therapy effectively improved acne keloidalis nuchae.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Biomedical imaging has greatly improved understanding and treatment of solid tumors.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.